Johnson & Johnson
A healthcare maker of prescription medicines — treatments for cancer, immune and nerve conditions, including DARZALEX and STELARA — plus medical devices such as ACUVUE contact lenses and surgical tools. Three Johnson brothers founded it in 1886 in New Jersey, inspired by a lecture on antiseptic surgery. Fun fact: an employee created BAND-AID bandages in 1920 for his wife, who kept cutting herself while cooking.
Granted 849.3K · Sold 225.8K
Granted 851.7K
Granted 383.5K · Sold 192.8K
Granted 15.6K
Granted 239.3K · Sold 78.9K
Granted 194.3K · Sold 168.6K
Granted 252.0K · Sold 134.3K
Granted 106.8K · Sold 69.8K
Granted 113.0K · Sold 73.3K
Granted 101.4K · Sold 63.1K
Granted 15.2K
Granted 101.6K · Sold 59.4K
Granted 153.7K · Sold 94.8K
Granted 65.4K · Sold 52.1K
Granted 59.4K · Sold 24.3K
Granted 48.7K
Granted 43.8K · Sold 15.1K
Granted 14.1K
Bought 1.3K
Bought 1.0K
Bought 100
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Duato JoaquinCEO and Chairman of the Board, Director · 46 transactions | — | 911.2K | 849.3K | — | 225.8K |
| Gorsky AlexDirector · 10 transactions | +50.8% | 768.3Kas of Jan 2023 | 851.7K | — | — |
| Taubert Jennifer LEVP, WWC. Innovative Medicine · 39 transactions | +68.9% | 194.5K | 383.5K | — | 192.8K |
| Ullmann Michael HExec VP, General Counsel · 4 transactions | +9.3% | 166.8Kas of Feb 2022 | 15.6K | — | — |
| Wengel Kathryn EEVP, Chief TO and Risk Officer · 47 transactions | +84.7% | 124.7K | 239.3K | — | 78.9K |
| Fasolo PeterExec VP, Chief HR Officer · 296 transactions | -0.4% | 112.5Kas of Feb 2024 | 194.3K | — | 168.6K |
| Wolk Joseph JExec VP, CFO · 53 transactions | — | 110.0K | 252.0K | — | 134.3K |
| Mongon ThibautExec VP, WW Chair, Cons Health · 53 transactions | +67.3% | 65.9Kas of Feb 2023 | 106.8K | — | 69.8K |
| McEvoy AshleyEVP, WW Chair, MedTech · 12 transactions | +67.4% | 55.1Kas of Aug 2023 | 113.0K | — | 73.3K |
| Swanson James D.EVP, CIO · 36 transactions | — | 46.2K | 101.4K | — | 63.1K |
| Mammen MathaiEVP, Pharm, R&D · 4 transactions | — | 41.9Kas of Feb 2022 | 15.2K | — | — |
| Hait WilliamSee Remarks · 30 transactions | — | 39.1Kas of Feb 2024 | 101.6K | — | 59.4K |
| Reed John CEVP, Innovative Medicine, R&D · 20 transactions | — | 35.9K | 153.7K | — | 94.8K |
| Decker Robert JVP Corporate Controller · 47 transactions | +93.9% | 28.5K | 65.4K | — | 52.1K |
| Schmid TimothyEVP, WW Chair, MedTech · 30 transactions | — | 26.2K | 59.4K | — | 24.3K |
| Forminard ElizabethEVP, Chief Legal Officer · 31 transactions | — | 23.5K | 48.7K | — | — |
| Broadhurst VanessaEVP, Global Corp Affairs · 35 transactions | — | 23.0K | 43.8K | — | 15.1K |
| Mulholland KristenEVP, Chief HR Officer · 18 transactions | — | 19.7K | 14.1K | — | — |
| Morikis John GDirector · 1 transaction | — | 1.8K | — | 1.3K | — |
| Weinberger Mark ADirector · 1 transaction | — | 1.0Kas of Dec 2024 | — | 1.0K | — |
| Johnson Paula ADirector · 1 transaction | — | 191as of Aug 2023 | — | — | — |
| Woods Eugene A.Director · 1 transaction | — | 150as of Feb 2025 | — | 100 | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -1.25M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.